K vs RYTM · P/E 23, $29.03B cap vs rev $130.1M
Kellanova (K) versus Rhythm Pharmaceuticals Inc (RYTM) — a side-by-side from cached financials, not a winner call.
Kellanova (K) is a packaged foods company listed on US.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
K does not have a complete income-statement cache yet.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
K currently screens at market cap $29.03B and trailing P/E 22.8. RYTM currently screens at market cap $6.49B.
Not investment advice. Open the K and RYTM stock pages for the full models.
Not investment advice.